Elevated beta-thromboglobulin levels and circulating platelet aggregates in diabetic microangiopathy

Area of Science:

• Biochemistry
• Hematology
• Endocrinology

Background:

• Diabetic microangiopathy is a common complication of diabetes mellitus.
• Platelet activation plays a potential role in the pathogenesis of microvascular disease.

Purpose of the Study:

• To investigate the relationship between beta-thromboglobulin levels, platelet aggregation, and diabetic microangiopathy.
• To assess the impact of glycemic control on these markers.

Main Methods:

• Blood samples were collected from healthy controls and diabetic patients (with and without microangiopathy).
• Measurements included beta-thromboglobulin levels and platelet-aggregate ratios.
• Changes were monitored in newly treated diabetics with improved blood glucose control.

Main Results:

• Diabetic patients with microangiopathy showed significantly elevated beta-thromboglobulin levels.
• Reversible platelet aggregates were also observed in these patients.
• Improved blood glucose control in nine newly treated diabetics led to a significant decrease in plasma beta-thromboglobulin.

Conclusions:

• Diabetic microangiopathy is associated with evidence of platelet activation.
• Beta-thromboglobulin, a platelet-specific protein, may serve as a marker for this activation.
• The degree of biochemical control appears to influence platelet activation in diabetic patients.